Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Conditions: Pancreatic Cancer Interventions: Drug: NP137 Sponsors: Nabeel Badri; NETRIS Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials